Schedule 13G ownership disclosure

SUNESIS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 867328502

Event date: 2016-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,133,583
Percent of class
5.4300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001389933-17-000010
Form type
SC 13G
Filer
DAFNA Capital Management LLC
CIK
CIK 1389933
Filed
Feb 14, 2017
Reporting period
Dec 31, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub